Injective INJ
Current Price
$3.66 +6.98%
$0.2900 Daily Range (7.92%)
$3.41$3.70
$61.72M Daily Volume
790 BTC
Vol/MktCap: 16.85%
Market Performance
0.15% Relative BTC Volume
The total volume of Injective is $61.72M over the past 24 hours, compared to $40.07B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.61 +1.47%
13 SMA $3.57 +2.53%
21 SMA $3.52 +3.98%
55 SMA $3.48 +5.03%
144 SMA $3.57 +2.51%
Price Performance
+1.76% 1 Hour Change
$3.66 from $3.60
+5.67% 7 Day Change
$0.2076 from $3.45
+8.51% 14 Day Change
$0.3115 from $3.35
+27.43% 30 Day Change
$1.00 from $2.66
All Time High
March 14, 2024
$52.62 -93.01%
-$48.94 vs. now
24H Change
24.45M USD +7.15%
313 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
17.36M INJ
traded over past 24 hours
17.36% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.64, reflecting a notable 6.46% increase over the past 24 hours. The daily trading range has been between $3.41 and $3.68, indicating healthy volatility and interest in the asset.
The trading volume stands at approximately $59.91 million, with a volume-to-market cap ratio of 16.47%, which suggests strong trading activity relative to its market capitalization. Short-term moving averages are bullish, with the 8 SMA at $3.61 showing a 0.92% increase, while longer-term SMAs also demonstrate positive trends, particularly the 55 SMA at $3.48, up 4.45%.
The 1-hour RSI is at 72, signaling that INJ may be overbought in the short term, which could lead to a pullback. Conversely, the 7-day RSI at 52 indicates that the asset is neither overbought nor oversold, suggesting potential for further upside.
The price has increased by approximately 25.91% over the last 30 days, reflecting strong bullish momentum and investor confidence. The all-time high of $52.62 reached in March 2024 indicates substantial growth potential, although the current price represents a significant retracement from that level.
Given the current price action, moving averages, and RSI indicators, the market sentiment for Injective appears bullish in the medium term. However, the high hourly RSI suggests a short-term consolidation or correction may be imminent.
In conclusion, the recommendation for Injective (INJ) is to Hold. The asset shows strong momentum and potential for future growth, but short-term overbought conditions warrant caution against new entries at this level.
The trading volume stands at approximately $59.91 million, with a volume-to-market cap ratio of 16.47%, which suggests strong trading activity relative to its market capitalization. Short-term moving averages are bullish, with the 8 SMA at $3.61 showing a 0.92% increase, while longer-term SMAs also demonstrate positive trends, particularly the 55 SMA at $3.48, up 4.45%.
The 1-hour RSI is at 72, signaling that INJ may be overbought in the short term, which could lead to a pullback. Conversely, the 7-day RSI at 52 indicates that the asset is neither overbought nor oversold, suggesting potential for further upside.
The price has increased by approximately 25.91% over the last 30 days, reflecting strong bullish momentum and investor confidence. The all-time high of $52.62 reached in March 2024 indicates substantial growth potential, although the current price represents a significant retracement from that level.
Given the current price action, moving averages, and RSI indicators, the market sentiment for Injective appears bullish in the medium term. However, the high hourly RSI suggests a short-term consolidation or correction may be imminent.
In conclusion, the recommendation for Injective (INJ) is to Hold. The asset shows strong momentum and potential for future growth, but short-term overbought conditions warrant caution against new entries at this level.
Updated 113 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

CFTC to legalize crypto perpetuals in US, boosting regulatory clarity
The CFTC's move could enhance U.S.

US Hits Iran With $500M Crypto Seizure In Major Financial Offensive
Iran’s currency has lost between 60% and 70% of its value against the US dollar. One of the country’s largest banks collapsed last December.

Price predictions 5/1: BTC, ETH, XRP, BNB, SOL, DOGE, HYPE, ADA, BCH, XMR
Technical charts suggest that Bitcoin’s rally continuation is fully dependent on bulls securing a weekly close above $75,000.

Canadian pension giant AIMCo buys the dip in Strategy, now sitting on $69 million unrealized gain
AIMCo returns to Michael Saylor's bitcoin treasury company years after exiting, now sitting on a sizable unrealized gain.